DETECTION OF RUBELLA VIRUS RNA IN CLINICALMATERIAL BY REAL TIME POLYMERASECHAIN REACTION METHOD
- Authors: Domonova EA1, Shipulina OY.1, Kuevda DA1, Larichev VF1, Safonova AP1, Burchik MA1, Butenko AM1, Shipulin GA1, Domonova EA2, Shipulina OY.2, Kuevda DA2, Larichev VF3, Safonova AP2, Burchik MA4, Butenko AM3, Shipulin GA2
-
Affiliations:
- Central Research Institute of Epidemiology, Moscow, Russia
- Ivanovsky Research Institute of Virology, Moscow, Russia
- Infectious Diseases Clinical Hospital No. 2, Moscow, Russia
- Issue: Vol 89, No 1 (2012)
- Pages: 60-67
- Section: Articles
- Submitted: 09.06.2023
- Published: 15.03.2012
- URL: https://microbiol.crie.ru/jour/article/view/13670
- ID: 13670
Cite item
Full Text
Abstract
of rubella virus RNA in clinical material by
PCR-RT. Materials and methods. During development
and determination of analytical specificity
and sensitivity DNA and RNA of 33
different microorganisms including 4 rubella
strains were used. Comparison of analytical
sensitivity of virological and molecular-biological
methods was performed by using rubella
virus strains Wistar RA 27/3, M-33, «Orlov»,
Judith. Evaluation of diagnostic informativity
of rubella virus RNA isolation in various clinical
material by PCR-RT method was performed in
comparison with determination of virus specific
serum antibodies by enzyme immunoassay.
Results. A reagent kit for the detection of rubella
virus RNA in clinical material by PCR-RT
was developed. Analytical specificity was 100%,
analytical sensitivity - 400 virus RNA copies
per ml. Analytical sensitivity of the developed
technique exceeds analytical sensitivity of the
Vero E6 cell culture infection method in studies
of rubella virus strains Wistar RA 27/3 and
«Orlov» by 1 lg and 3 lg, and for M-33 and Judith
strains is analogous. Diagnostic specificity is
100%. Diagnostic specificity for testing samples
obtained within 5 days of rash onset: for peripheral
blood sera - 20.9%, saliva - 92.5%, nasopharyngeal
swabs - 70.1%, saliva and nasopharyngeal
swabs - 97%. Positive and
negative predictive values of the results were
shown depending on the type of clinical material
tested. Conclusion. Application of reagent
kit will allow to increase rubella diagnostics effectiveness
at the early stages of infectious process
development, timely and qualitatively perform
differential diagnostics of exanthema
diseases, support tactics of anti-epidemic regime.
Keywords
About the authors
E A Domonova
O Yu Shipulina
D A Kuevda
V F Larichev
A P Safonova
M A Burchik
A M Butenko
G A Shipulin
E A Domonova
Central Research Institute of Epidemiology, Moscow, RussiaCentral Research Institute of Epidemiology, Moscow, Russia
O Yu Shipulina
Central Research Institute of Epidemiology, Moscow, RussiaCentral Research Institute of Epidemiology, Moscow, Russia
D A Kuevda
Central Research Institute of Epidemiology, Moscow, RussiaCentral Research Institute of Epidemiology, Moscow, Russia
V F Larichev
Ivanovsky Research Institute of Virology, Moscow, RussiaIvanovsky Research Institute of Virology, Moscow, Russia
A P Safonova
Central Research Institute of Epidemiology, Moscow, RussiaCentral Research Institute of Epidemiology, Moscow, Russia
M A Burchik
Infectious Diseases Clinical Hospital No. 2, Moscow, RussiaInfectious Diseases Clinical Hospital No. 2, Moscow, Russia
A M Butenko
Ivanovsky Research Institute of Virology, Moscow, RussiaIvanovsky Research Institute of Virology, Moscow, Russia
G A Shipulin
Central Research Institute of Epidemiology, Moscow, RussiaCentral Research Institute of Epidemiology, Moscow, Russia
References
- ГОСТ Р 53079.1-2008. Технологии лабораторные клинические. Обеспечение качества клинических лабораторных исследований. Часть 1. Правила описания методов исследования. М., Стандартинформ, 2009.
- ГОСТ Р 53022.2-2008. Технологии лабораторные клинические. Требования к качеству клинических лабораторных исследований. Часть 2. Оценка аналитической надежности методов исследования (точность, чувствительность, специфичность). М., Стандартинформ, 2009.
- ГОСТ Р 53022.3-2008. Технологии лабораторные клинические. Требования к качеству клинических лабораторных исследований. Часть 3. Правила оценки клинической информативности лабораторных тестов. М., Стандартинформ, 2009.
- Десятскова Р.Г., Заргарьянц А.И., Степанов А.В. и др. Авидность иммуноглобулина G к вирусу краснухи при поствакцинальном и постинфекционном иммунитете. Журн. микробиол. 2007, 4: 6-11.
- Кицак В.Я. Вирусные инфекции беременных: патология плода и новорожденных. Кольцово, 2004.
- Руководство по лабораторной диагностике кори и краснухи. Вторая редакция. Женева, 2007.
- Руководство по эпидемиологическому надзору за корью, краснухой и синдромом врожденной краснухи в Европейском регионе ВОЗ. Копенгаген,2010.
- Эпидемиологический надзор за корью, краснухой и эпидемическим паротитом: Методические указания. МУ 3.1.2.1177-02. М., Федеральный центр госсанэпиднадзора Минздрава России, 2003.
- Эпидемиологический надзор за врожденной краснухой. Методические указания. МУ 3.1.2.2356-08. М., 2008.
- Banatvala J.E. Clinical features: post-natally acquired rubella. In: Banatvala J.E., Peckham C. (ed). Perspectives in medical virology. 15. Rubella viruses. Amsterdam, Elsevier, 2007, р. 19-37.
- Best J.M., O'Shea S., Tipples G. et al. Interpretation of rubella serology in pregnancy - pitfalls and problems. BMJ. 2002, 325 (7356): 147-148.
- Best J.M., Enders G. Laboratory diagnosis of rubella and congenital rubella. In: Banatvala J.E., Peckham C. (ed). Perspectives in medical virology. 15. Rubella viruses. Amsterdam, Elsevier, 2007, р. 39-78.
- Epidemiology and prevention of vaccinepreventable diseases. Atlanta, 2004.
- Pasloske B.L., Walkerpeach C.R., Obermoeller R.D. et al. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J. Clin. Microbiol. 1998, 36: 3590-3594.
- Standardization of the nomenclature for genetic characteristics of wild-type rubella viruses. Wkly Epidemiol. Rec. 2005, 80 (14): 126-132.